Immunology: Current Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Article   
  • Immunol Curr Res 2023, Vol 7(1): 128

Antibiotic Supplementation's Immunostimulatory Benefits on Asthma Patients: A Randomised, Double-Blind, Placebo-Controlled Trial

Dr. Clara Farrokhi*
Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
*Corresponding Author : Dr. Clara Farrokhi, Department of Immunology, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran, Email: rrokhi23@gmail.com

Received Date: Jan 05, 2023 / Accepted Date: Jan 29, 2023 / Published Date: Jan 30, 2023

Abstract

Background: Asthma is seen as an ongoing inflammatory condition of the airways. Living bacteria called probiotics are prevalent in the human stomach and have been shown to be protective against a variety of illnesses, including allergies. This study sought to better understand how probiotic treatment for asthma affected patients' clinical symptoms, changes in the expression pattern of specific microRNAs, and changes in plasma levels of IL-4 and IFN-.
Materials and methods: 40 asthmatic patients participated in the current investigation, which was a randomised,double-blind, placebo-controlled trial. Probiotics or a placebo was given orally once day for eight weeks. The expression of microRNAs, IL-4 and IFN- levels, and pulmonary function tests were evaluated before and after treatment.
Results: The findings demonstrated that probiotic supplementation dramatically decreased the expression of miR-16, miR146-a, and IL-4 levels in asthma patients while considerably increasing the expression of miR-133b.Furthermore, following taking probiotics, pulmonary function tests revealed a significantly improved Forced Expiratory Volume in 1 s and Forced Vital Capacity.
Conclusion: In our investigation, an 8-week probiotic supplementation regimen decreased IL-4 linked with Th2 cells and increased forced vital capacity and forced expiratory volume. The use of probiotics seems to be an option in addition to conventional asthma therapies.

Citation: Farrokhi C (2023) Antibiotic Supplementation's ImmunostimulatoryBenefits on Asthma Patients: A Randomized, Double-Blind, Placebo-ControlledTrial. Immunol Curr Res, 7: 128.

Copyright: © 2023 Farrokhi C. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top